ZINERYT 40mg / 12mg / ml powder+solvent for cutaneous solution medication leaflet

D10AF52 erythromycin + zinc acetate • Dermatologicals | Anti-acne preparations for topical use | Antiinfectives for treatment of acne

The combination of erythromycin and zinc acetate is used in the treatment of acne vulgaris, particularly for mild to moderate cases. It combines the antibacterial and anti-inflammatory effects of erythromycin with the healing and regenerative properties of zinc, providing an effective solution for reducing acne lesions.

- Erythromycin is a macrolide antibiotic that inhibits the growth of bacteria involved in acne, such as Cutibacterium acnes. It reduces inflammation and prevents the formation of new acne lesions.
- Zinc acetate has anti-inflammatory properties and helps reduce sebum production, accelerating the healing of acne-affected skin. Zinc also contributes to tissue regeneration and reduces irritation.

This combination is available as a solution or gel and is applied topically, usually twice daily, on clean and dry skin.

Common side effects include local irritation, redness, dryness, or a burning sensation at the application site. These reactions are usually mild and temporary. It is important to avoid contact with the eyes, mouth, or other sensitive areas.

Patients should strictly follow their doctor’s instructions and avoid using other irritating products (such as harsh exfoliants or alcohol-based products) during treatment. The combination is not recommended for pregnant or breastfeeding women without medical advice.

General data about ZINERYT 40mg / 12mg / ml

Substance: erythromycin + zinc acetate

Date of last drug list: 10-04-2026

Commercial code: W67797001

Concentration: 40mg / 12mg / ml

Pharmaceutical form: powder+solvent for cutaneous solution

Quantity: 1

Product type: original

Price: 41.17 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ASTELLAS PHARMA EUROPE B.V. - OLANDA

Holder: CHEPLAPHARM ARZNEIMITTEL GMBH - GERMANIA

Number: 7452/2015/01

Shelf life: 3 years;Dupa ambalare pentru comercializare;Dupa reconstituire - 5 saptamâni

Other substances similar to erythromycin + zinc acetate

Compensation lists for ZINERYT 40mg / 12mg / ml CHEPLAPHARM

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

41.17 RON

41.17 RON

0.00 RON